BGI Genomics H1 2026 Net Profit Surges 718.24% to RMB 47.4046 Million
On August 21, 2026, BGI Genomics disclosed its semi-annual report for the first half of 2026. The company achieved operating revenue of RMB 1.789 billion, up 9.59% year-on-year; net profit attributable to shareholders was RMB 47.4046 million, up 718.24% year-on-year; and basic earnings per share was RMB 0.1133.
Why this event matters
The event has a measured impact on 1 industry. The strongest current signal is positive for Biotechnology, with intensity 60/100 and 70% confidence over a short term horizon.
Impact figures are analytical estimates that combine direction, intensity, confidence and event importance. They are not investment advice.